U.S. Auto Stock News

We'd be surprised if Univest Financial Corporation ( NASDAQ:UVSP ) shareholders haven't noticed that the Independent...

Earlier in April 2026, Transocean Ltd. announced that its Deepwater Asgard rig secured a five-well contract in the Eastern Mediterranean, an estimated 390-day campaign starting in late 2026 that adds about US$158 million to its backlog, excluding mobilization and additional service revenues. Including this contract and recent awards in Norway and Brazil, Transocean’s backlog has grown by around US$1.60 billion since early April, underscoring how fresh long-term commitments can support...

Trade Desk (NasdaqGM:TTD) has been named the first and exclusive demand-side platform partner for DramaBox. The partnership opens programmatic access to DramaBox’s vertical short drama content for global advertisers. This agreement expands the range of digital video inventory available through Trade Desk’s platform. Trade Desk operates a programmatic advertising platform that connects advertisers with digital inventory across the open internet, including video, audio, mobile and connected...

Church & Dwight stock overview Church & Dwight (CHD) has drawn investor attention after recent share price gains, with the stock up over the past week, month and past 3 months, prompting a closer look at its fundamentals and valuation. See our latest analysis for Church & Dwight. Beyond the recent uptick, Church & Dwight shows a 17.47% year to date share price return, while its 1 year total shareholder return decline of 0.67% points to building short term momentum compared with more muted...

Recent performance snapshot and what it means for investors Taiwan Semiconductor Manufacturing (NYSE:TSM) has drawn attention after a 1 day return of about a 3.1% decline, alongside gains of roughly 6.6% over the past week and 20% over the past month. Over the past 3 months the stock shows a total return near 14.6%, with year to date performance around 22.8%. Over 1 year, 3 years, and 5 years, total returns are approximately 140.8%, 3.9x, and 2.6x respectively. See our latest analysis for...

For investors considering whether TransDigm Group at around US$1,154 per share represents an opportunity or is already fully reflecting its quality, this article walks through what the current market price might be indicating about the stock. The share price has seen a 4.3% decline over the last 7 days, a 1.2% gain over 30 days, a 15.1% decline year to date, a 12.4% decline over 1 year, a 74.9% gain over 3 years and a 132.7% gain over 5 years, giving you a mix of shorter term weakness and...

AGNC Investment Corp. reported first-quarter 2026 results showing a net loss of US$148 million, or US$0.17 loss per share from continuing operations, compared with net income and earnings per share a year earlier. Despite this headline loss, the company’s strong core operating performance, wider net interest spread, and continued dividend record have drawn renewed institutional interest and debate about whether the shares remain undervalued. We’ll now examine how AGNC’s strong core...

Wondering if Solventum at around US$67.51 is offering value or just noise in the healthcare space? This article walks you through what the current price could mean for you. Over the short term, Solventum has seen a 2.1% decline over the last 7 days, a 7.6% return over 30 days, and a 14.6% decline year to date, while the 1 year return sits at 1.9%. Recent coverage of Solventum has focused on its position in the Medical Equipment industry and how investors are reacting to its standalone...

Investors may be wondering if CareTrust REIT at around US$39.71 is offering good value right now, or if the recent excitement has already been priced in. The stock has seen returns of 3.5% over the last 7 days, 6.9% over the last 30 days, 9.4% year to date, 43.6% over 1 year, 136.5% over 3 years and 118.6% over 5 years, which puts recent price moves front and center for any valuation check. Recent news coverage has focused on CareTrust REIT as a health care focused REIT, with attention on...

Permian Resources has recently drawn attention after analysts highlighted its strong record of beating earnings expectations and flagged a positive setup for another potential earnings surprise ahead of its early May 2026 quarterly report. This ongoing pattern of outperformance against forecasts is sharpening focus on how effectively the company converts operational execution into consistent earnings resilience. We’ll now examine how this renewed optimism around another possible earnings...

If you are wondering whether Kemper's current share price fairly reflects the business, the next sections will walk through what the numbers are actually saying about value. The stock last closed at US$33.62, with returns of 2.1% over the past week and 12.4% over the past month, set against a 15.0% decline year to date and a 42.0% decline over the past year. Recent headlines around Kemper have focused on its position in the US insurance space and how the market is reassessing risk and...

Metropolitan Bank Holding (MCB) has drawn fresh investor attention after reporting first quarter results that included higher net interest income and net income year over year, along with an increase in its regular quarterly dividend. See our latest analysis for Metropolitan Bank Holding. The latest earnings and dividend announcement have come alongside a 1 month share price return of 12.65% and an 18.03% year to date share price return, while the 3 year total shareholder return is very...

Investors may be wondering whether Alnylam Pharmaceuticals, at around US$302 a share, still offers value or if most of the opportunity has already been priced in. The stock has had a mixed return profile lately, with a 2.7% decline over the last 7 days, a 4.4% decline over 30 days, a 14.8% gain over 1 year, and a 127.7% gain over 5 years, which may have shifted how some investors think about its risk and reward. Recent coverage around the company has focused on its role in the biotech space...

If you are trying to figure out whether Super Group (SGHC) is genuinely good value or just looks that way on the surface, the recent share price action gives you plenty to think about. The stock last closed at US$12.34, with returns of 18.3% over 30 days, 6.0% year to date, and 58.3% over 1 year, while the 7 day return was a modest 0.5% decline. Recent coverage has centered on Super Group's position within the online betting and gaming space and how regulatory developments and competitive...

General Motors (GM) opened 2026 with Q1 results that put the focus squarely on profitability, reporting revenue of US$43.6 billion and net income of US$2.6 billion, which translated into basic EPS of US$2.88 for the quarter. Over the past year, the company has seen quarterly revenue move in a tight band between US$43.6 billion and US$48.6 billion, while basic EPS has swung from a quarterly high of US$3.40 to a loss of US$3.60, setting up a sharp contrast between steady top line performance...

Baker Hughes has secured a major contract to supply LNG equipment for Qatar's North Field West expansion. The award ties the company to one of the world's largest LNG projects while Middle East disruptions and supply chain challenges continue. The contract focuses on critical hardware for LNG production, reinforcing demand for Baker Hughes' gas focused technology. Baker Hughes, listed as NasdaqGS:BKR, is drawing new attention as this contract adds to an already active year for its...

The Morning Bull - US Market Morning Update Wednesday, Apr, 29 2026 US stock futures are slightly higher this morning, with E mini S&P 500 and Nasdaq 100 contracts edging up as investors wait for the Federal Reserve’s April meeting. The Fed is widely expected to keep its main interest rate unchanged, which effectively decides how expensive mortgages, credit cards and business loans feel. At the same time, the 10 year US Treasury yield is sitting near 4.35% while oil inventories fell by about...

GE HealthCare Technologies (GEHC) has kicked off its international Phase 2/3 LUMINA trial, dosing the first patient with mangaciclanol, a manganese based MRI contrast agent that has been granted FDA Fast Track status. See our latest analysis for GE HealthCare Technologies. The latest product and AI partnerships are arriving at a time when momentum has softened, with a 1 day share price return of 2.81% decline, a 90 day share price return of 13.58% decline, and a 1 year total shareholder...

American Airlines Group (NasdaqGS:AAL) publicly rejected rumors of a mega merger with United Airlines, stating such a deal would be harmful for competition and consumers. The company addressed the speculation directly in a rare, categorical statement, signaling clear opposition to large scale industry consolidation. At its upcoming AGM, American Airlines faces activist shareholder proposals related to voting processes, officer liability limits and other governance topics. The company is also...

In recent weeks, Synaptics has highlighted progress in its Edge AI push, including the Astra processor family developed with Google Research and early customer uptake, alongside strong Core IoT segment growth and new engagement with a major humanoid robotics client. This combination of native on-device AI capabilities and expanding IoT design wins signals a meaningful shift in Synaptics’ role within next-generation connected devices. Next, we’ll examine how Synaptics’ Astra Edge AI launch...

Those following along with The Simply Good Foods Company ( NASDAQ:SMPL ) will no doubt be intrigued by the recent...

Q1 earnings and guidance set the tone Coursera (COUR) reported first quarter 2026 results with sales of US$195.7 million and a net loss of US$20.5 million, while also issuing second quarter revenue guidance and reaffirming its full year 2026 outlook. See our latest analysis for Coursera. The Q1 earnings release and reaffirmed 2026 revenue outlook arrived alongside a sharp 11.7% 1 day share price return to US$6.49. However, Coursera’s 1 year total shareholder return of 23.01% decline and 5...

Philip Morris International (NYSE:PM) has committed a $30,000 donation to the Acadiana Veteran Alliance in the U.S. The funding supports veteran entrepreneurs and local business formation as part of a broader corporate citizenship approach. This initiative reflects an expansion of the company’s U.S. engagement beyond smoke free products and related messaging. For investors tracking Philip Morris International at a current share price of $165.89, this move adds another piece to the overall...

Thermo Fisher Scientific (NYSE:TMO) agreed to sell its microbiology business to Astorg for more than US$1b. The transaction reflects a shift in focus away from specialty diagnostics toward biopharma services and biologics. The company also opened a new U.S. Bioprocess Design Center aimed at supporting biologics development and manufacturing. For you as an investor, these moves highlight where Thermo Fisher Scientific, a major player in life science tools and diagnostics, is choosing to...